Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Sales (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Return on Sales for 16 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 8.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.06% through Dec 2025, up 11.0% year-over-year, with the annual reading at 0.06% for FY2025, 11.0% up from the prior year.
  • Return on Sales hit 0.1% in Q4 2025 for Cumberland Pharmaceuticals, up from 0.24% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.11% in Q1 2025 to a low of 0.67% in Q4 2023.
  • Historically, Return on Sales has averaged 0.07% across 5 years, with a median of 0.01% in 2022.
  • Biggest YoY gain for Return on Sales was 49bps in 2024; the steepest drop was -24bps in 2024.
  • Year by year, Return on Sales stood at 0.06% in 2021, then tumbled by -80bps to 0.01% in 2022, then crashed by -5616bps to 0.67% in 2023, then skyrocketed by 73bps to 0.18% in 2024, then soared by 43bps to 0.1% in 2025.
  • Business Quant data shows Return on Sales for CPIX at 0.1% in Q4 2025, 0.24% in Q3 2025, and 0.07% in Q2 2025.